CIK 0001280776 · Non-accelerated filer<br>Smaller reporting company
IMMUNIC, INC.
Sign in to watch- Ticker
- IMUX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562358443
- Phone
- (332) 255-9818
- Business address
- 1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK, United States, 10036
- Former names
- VITAL THERAPIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-04 | Nash Duane Executive Chairman | Returned to the company · Stock Option | −10,000 | 0 | ||
| 2024-03-04 | Nash Duane Executive Chairman | Grant or award · Stock Option | +379,959 | 379,959 | ||
| 2024-03-04 | PHILLIPS BARCLAY A Director | Returned to the company · Stock Option | −19,973 | 0 | ||
| 2024-03-04 | PHILLIPS BARCLAY A Director | Returned to the company · Stock Option | −9,986 | 0 | ||
| 2024-03-04 | PHILLIPS BARCLAY A Director | Returned to the company · Stock Option | −15,000 | 0 | ||
| 2024-03-04 | PHILLIPS BARCLAY A Director | Returned to the company · Stock Option | −10,000 | 0 | ||
| 2024-03-04 | PHILLIPS BARCLAY A Director | Returned to the company · Stock Option | −10,000 | 0 | ||
| 2024-03-04 | PHILLIPS BARCLAY A Director | Grant or award · Stock Option | +64,959 | 64,959 | ||
| 2024-03-04 | Vitt Daniel President and CEO | Returned to the company · Stock Option | −65,000 | 0 | ||
| 2024-03-04 | Vitt Daniel President and CEO | Returned to the company · Stock Option | −80,000 | 0 | ||
| 2024-03-04 | Vitt Daniel President and CEO | Returned to the company · Stock Option | −115,000 | 0 | ||
| 2024-03-04 | Vitt Daniel President and CEO | Returned to the company · Stock Option | −215,000 | 0 | ||
| 2024-03-04 | Vitt Daniel President and CEO | Returned to the company · Stock Option | −10,000 | 0 | ||
| 2024-03-04 | Vitt Daniel President and CEO | Grant or award · Stock Option | +485,000 | 485,000 | ||
| 2024-03-04 | Muehler Andreas Chief Medical Officer | Returned to the company · Stock Option | −100,000 | 0 | ||
| 2024-03-04 | Muehler Andreas Chief Medical Officer | Returned to the company · Stock Option | −10,000 | 0 | ||
| 2024-03-04 | Muehler Andreas Chief Medical Officer | Returned to the company · Stock Option | −65,000 | 0 | ||
| 2024-03-04 | Muehler Andreas Chief Medical Officer | Returned to the company · Stock Option | −44,000 | 0 | ||
| 2024-03-04 | Muehler Andreas Chief Medical Officer | Returned to the company · Stock Option | −10,000 | 0 | ||
| 2024-03-04 | Muehler Andreas Chief Medical Officer | Returned to the company · Stock Option | −30,000 | 0 |
Page 6 of 9 · 170 trades